Chrome Holding (formerly 23andMe) sells Lemonaid telehealth for $10M in cash plus cure payments

Chrome Holding Co.

Bambumeta Ventures to acquire Lemonaid Health and Chrome Pharmacy Holdings for $10M cash, plus cure payments.
Purchase price is a higher offer than the prior $2.5M from TTAM; $2.5M deposit already placed.
Sale subject to Court approval of Chapter 11 plan and regulatory pharmacy license transfers; closing by Dec 1, 2025 (extendable to Jan 30, 2026).
Guarantor Bambumeta Ventures guarantees the Purchase Price; stock purchase agreement entered Sept 10, 2025.

item 1.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.